• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体和APRO家族蛋白在癌症干细胞靶向恶性肿瘤治疗发展中的潜在作用。

Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy.

作者信息

Nakashima Moeka, Suga Naoko, Fukumoto Akari, Yoshikawa Sayuri, Matsuda Satoru

机构信息

Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara, 630-8506, Japan.

出版信息

Oncol Res. 2025 Apr 18;33(5):1007-1017. doi: 10.32604/or.2025.059657. eCollection 2025.

DOI:10.32604/or.2025.059657
PMID:40296902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12034005/
Abstract

Malignant tumors are heterogeneous diseases characterized by uncontrolled cell proliferation, invasion, metastasis, and/or recurrence of their malignancies. In particular, cancer stem cells (CSCs) within these tumors might be responsible for the property of invasiveness and/or therapies-resistance. CSCs are a self-renewing, awfully tumorigenic subpopulation of cancer cells, which are notorious for strong chemoresistance and are frequently responsible the aggravated invasion, metastasis, and/or recurrence. Developing targeting therapies against CSCs, therefore, may be deliberated a more encouraging mission for the greater cancer therapy. Innovation for a more potent anti-CSC treatment has been required as soon as possible. Interestingly, vitamin D could modulate the inflammatory condition of the tumor microenvironment (TME) by successfully affecting CSCs, which has an imperative role in determining the malignant phenotype of CSCs. In addition, vitamin D may also contribute to the regulation of the malignant behaviors of CSCs. Consistently, vitamin D could have potential applications for the significant inhibition of several tumor growths within various cancer therapies. The biological significance of vitamin D for CSCs regulation may be involved in the function of APRO family proteins. Therefore, vitamin D could be one of the innovative therapeutic modalities for the development of novel CSCs related tumor therapies.

摘要

恶性肿瘤是异质性疾病,其特征在于细胞不受控制地增殖、侵袭、转移和/或恶性肿瘤复发。特别是,这些肿瘤中的癌症干细胞(CSCs)可能是侵袭性和/或治疗抗性的原因。CSCs是癌细胞中具有自我更新能力、极具致瘤性的亚群,以强烈的化学抗性而臭名昭著,并且经常导致侵袭、转移和/或复发加剧。因此,开发针对CSCs的靶向治疗可能被认为是一项更具前景的重大癌症治疗任务。迫切需要尽快创新出更有效的抗CSC治疗方法。有趣的是,维生素D可以通过成功影响CSCs来调节肿瘤微环境(TME)的炎症状态,这在决定CSCs的恶性表型方面起着至关重要的作用。此外,维生素D也可能有助于调节CSCs的恶性行为。同样,在各种癌症治疗中,维生素D对于显著抑制多种肿瘤生长可能具有潜在应用价值。维生素D对CSCs调节的生物学意义可能涉及APRO家族蛋白的功能。因此,维生素D可能是开发新型CSCs相关肿瘤治疗方法的创新治疗方式之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/10167d96a70c/OncolRes-33-59657-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/0a3a3f09627a/OncolRes-33-59657-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/1995dc5e4a0b/OncolRes-33-59657-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/10167d96a70c/OncolRes-33-59657-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/0a3a3f09627a/OncolRes-33-59657-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/1995dc5e4a0b/OncolRes-33-59657-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae81/12034005/10167d96a70c/OncolRes-33-59657-f003.jpg

相似文献

1
Promising roles of vitamin D receptor and APRO family proteins for the development of cancer stem cells targeted malignant tumor therapy.维生素D受体和APRO家族蛋白在癌症干细胞靶向恶性肿瘤治疗发展中的潜在作用。
Oncol Res. 2025 Apr 18;33(5):1007-1017. doi: 10.32604/or.2025.059657. eCollection 2025.
2
Stem cell programs in cancer initiation, progression, and therapy resistance.肿瘤起始、进展和治疗抵抗中的干细胞程序。
Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020.
3
Targeting cancer stem cells in solid tumors by vitamin D.维生素D靶向实体瘤中的癌症干细胞。
J Steroid Biochem Mol Biol. 2015 Apr;148:79-85. doi: 10.1016/j.jsbmb.2014.10.007. Epub 2014 Oct 16.
4
Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.不断发展的癌症干细胞治疗靶点策略。
Adv Cancer Res. 2016;131:159-91. doi: 10.1016/bs.acr.2016.04.003. Epub 2016 Jun 3.
5
Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.基于癌症干细胞的治疗方法的新兴功能标志物:了解用于靶向转移的信号网络。
Semin Cancer Biol. 2018 Dec;53:90-109. doi: 10.1016/j.semcancer.2018.06.006. Epub 2018 Jun 30.
6
Cancer stem cells and tumor-associated macrophages as mates in tumor progression: mechanisms of crosstalk and advanced bioinformatic tools to dissect their phenotypes and interaction.癌症干细胞与肿瘤相关巨噬细胞在肿瘤进展中的协同作用:相互作用机制及剖析其表型与相互作用的先进生物信息学工具
Front Immunol. 2025 Feb 6;16:1529847. doi: 10.3389/fimmu.2025.1529847. eCollection 2025.
7
Cancer Stem Cells: Root of the Evil.癌症干细胞:万恶之源。
Crit Rev Oncog. 2019;24(1):69-87. doi: 10.1615/CritRevOncog.2019029512.
8
Cancer stem cells (CSCs) in cancer progression and therapy.癌症进展和治疗中的癌症干细胞 (CSCs)。
J Cell Physiol. 2019 Jun;234(6):8381-8395. doi: 10.1002/jcp.27740. Epub 2018 Nov 11.
9
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.肿瘤微环境中癌症干细胞治疗靶点的研究进展:最新综述
Cells. 2020 Aug 13;9(8):1896. doi: 10.3390/cells9081896.
10
Cancer stem cell (CSC) resistance drivers.癌症干细胞(CSC)耐药性驱动因素。
Life Sci. 2019 Oct 1;234:116781. doi: 10.1016/j.lfs.2019.116781. Epub 2019 Aug 17.

本文引用的文献

1
Vitamin D suppresses CD133+/CD44 + cancer stem cell stemness by inhibiting NF-κB signaling and reducing NLRP3 expression in triple-negative breast cancer.维生素D通过抑制核因子κB信号传导并降低三阴性乳腺癌中NLRP3的表达来抑制CD133+/CD44+癌干细胞的干性。
Cancer Chemother Pharmacol. 2024 Jul;94(1):67-78. doi: 10.1007/s00280-024-04660-w. Epub 2024 Mar 8.
2
Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma.肠道微生物组与癌症:从癌症发展到治疗,特别关注肝细胞癌。
Front Biosci (Landmark Ed). 2024 Feb 6;29(2):67. doi: 10.31083/j.fbl2902067.
3
Roseburia intestinalis sensitizes colorectal cancer to radiotherapy through the butyrate/OR51E1/RALB axis.
肠道罗斯伯里菌通过丁酸/OR51E1/RALB 轴使结直肠癌对放疗敏感。
Cell Rep. 2024 Mar 26;43(3):113846. doi: 10.1016/j.celrep.2024.113846. Epub 2024 Feb 26.
4
Ailanthone induces autophagy and ferroptosis in non‑small cell lung cancer Lewis cells.臭椿酮诱导非小细胞肺癌Lewis细胞发生自噬和铁死亡。
Mol Clin Oncol. 2024 Feb 5;20(3):25. doi: 10.3892/mco.2024.2723. eCollection 2024 Mar.
5
Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.参与MAFLD发生发展的环状RNA、非编码RNA和N6-甲基腺苷
Noncoding RNA. 2024 Feb 5;10(1):11. doi: 10.3390/ncrna10010011.
6
Gut microbiota modulate CD8 T cell immunity in gastric cancer through Butyrate/GPR109A/HOPX.肠道微生物群通过丁酸/GPR109A/HOPX 调节胃癌中的 CD8 T 细胞免疫。
Gut Microbes. 2024 Jan-Dec;16(1):2307542. doi: 10.1080/19490976.2024.2307542. Epub 2024 Feb 6.
7
Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury.口服粪便移植可富集lachnospiraceae 并增加丁酸以减轻急性肝损伤。
Cell Rep. 2024 Jan 23;43(1):113591. doi: 10.1016/j.celrep.2023.113591. Epub 2023 Dec 27.
8
Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)D in A431 squamous cell carcinoma.解析 VDR 和 RXRA 对 1,25(OH)D 在 A431 鳞状细胞癌细胞中基因组活性的影响。
Mol Cell Endocrinol. 2024 Mar 1;582:112124. doi: 10.1016/j.mce.2023.112124. Epub 2023 Dec 19.
9
A pan-cancer analysis of anti-proliferative protein family genes for therapeutic targets in cancer.泛癌症分析抗增殖蛋白家族基因在癌症治疗靶点中的作用。
Sci Rep. 2023 Dec 7;13(1):21607. doi: 10.1038/s41598-023-48961-1.
10
Butyrate ameliorated ferroptosis in ulcerative colitis through modulating Nrf2/GPX4 signal pathway and improving intestinal barrier.丁酸盐通过调节 Nrf2/GPX4 信号通路和改善肠道屏障来改善溃疡性结肠炎中的铁死亡。
Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166984. doi: 10.1016/j.bbadis.2023.166984. Epub 2023 Dec 6.